Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • MJFF Research Grant, 2010
    Physiological and Pathological Implications of the Unique Subcellular Distribution of LRRK2

    Objective/Rationale: 
    Mutations in the LRRK2 gene are now recognized as the most common genetic cause of Parkinson’s disease, responsible for not only several inherited forms of this movement disorder...

  • MJFF Research Grant, 2010
    Parkinson's Disease NeuroEPIC: A Study of Genes and the Environment

    Objective/Rationale: 
    We will take advantage of the large European Prospective Investigation in Cancer (EPIC), a unique resource involving almost 500,000 participants from 10 European countries, with...

  • Novel Approaches to Drug Discovery, 2010
    Optimizing Metalloporphryins for Clinical Development Supplement

    Promising Outcomes of Original Grant:
    The overall goal of this ongoing proposal is to determine if a newly developed series of metalloporphyrins designed to penetrate blood brain barrier shows promise...

  • MJFF Research Grant, 2010
    Technology for Clinicogenetic Studies of LRRK2 G2019S in Tunisia

    Objective/Rationale:
    We seek to create and enhance a secure database, accessible by collaborators with customizable, user-friendly, web-based entry for clinical, genetic and pedigree information. This...

  • MJFF Research Grant, 2010
    The Parkinson's Progression Markers Initiative (PPMI)

    Objective/Rationale:
    Currently there is no definitive diagnostic test for Parkinson’s disease (PD) in a live patient, and no way to track disease progression on a biological level. These gaps have...

  • Rapid Response Innovation Awards, 2010
    Testing Whether Alpha-Synuclein is Modified by 4-hydroxy-2-nonenal in the Human Brain

    Promising Outcomes of Original Grant:
    The major goal of our grant application was to test whether a protein known as alpha-synuclein becomes toxic to dopamine-secreting nerve cells when it is modified...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.